Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells

被引:16
作者
Uemura, Y [1 ]
Kobayashi, M [1 ]
Nakata, H [1 ]
Harada, R [1 ]
Kubota, T [1 ]
Taguchi, H [1 ]
机构
[1] Kochi Med Sch, Dept Internal Med, Nanko Ku, Kochi 7838505, Japan
关键词
serum deprivation; G-CSF; GM-CSF; OKa-C-1; MI-4;
D O I
10.1002/ijc.20023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously established 2 lung cancer cell lines, OKa-C-I and MI-4, which constitutively produce an abundant dose of granulocyte-colony stimulating factor (G-CSF) and granulocyte macrophage-colony stimulating factor (GM-CSF). Many other cases with G-CSF or GM-CSF producing tumors have been reported up to the present. However, the biological properties of the overproduction of G-CSF and GM-CSF by tumor cells have not been well known. Several reports demonstrated the presence of an autocrine growth loop for G- CSF and GM-CSF in nonhematopoietic tumor cells. We showed that exogenous G-CSF and GM-CSF stimulated cell growth in a dose-dependent manner in OKa-C-I and MI-4 cells. We could detect the presence of G-CSF and GM-CSF receptors in both cell lines by RT-PCR analysis. We have previously shown that inflammatory cytokines, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta enhance the expression of G-CSF and GM-CSF in the cell lines. However, the factors that regulate constitutive production of G-CSF or GM-CSF by tumor cells are still unknown well. In our study, we first reported that serum deprivation stimulated constitutive production of G-CSF and GM-CSF by lung tumor cells through activation of nuclear factor (NF)-kappaB and p44/42 mitogen-activated protein kinase (MAPK) pathway signaling. We suggest that G-CSF and GM-CSF constitutively produced by tumor cells could grow tumor itself and rescue tumor cells from the cytotoxicity of serum deprivation. (C) 2004 Wilely-Liss, Inc.
引用
收藏
页码:826 / 832
页数:7
相关论文
共 46 条
[1]   ONCOGENE JUN ENCODES A SEQUENCE-SPECIFIC TRANS-ACTIVATOR SIMILAR TO AP-1 [J].
ANGEL, P ;
ALLEGRETTO, EA ;
OKINO, ST ;
HATTORI, K ;
BOYLE, WJ ;
HUNTER, T ;
KARIN, M .
NATURE, 1988, 332 (6160) :166-171
[2]   Establishment of a clonal cell line producing granulocyte colony-stimulating factor and parathyroid hormone-related protein from a lung cancer patient with leukocytosis and hypercalcemia [J].
Asahi, Y ;
Kubonishi, I ;
Imamura, J ;
Kamioka, M ;
Matsushita, H ;
Furihata, M ;
Ohtsuki, Y ;
Miyoshi, I .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (05) :451-458
[3]  
ASANO S, 1977, BLOOD, V49, P845
[4]   Agonists to the A3 adenosine receptor induce G-CSF production via NF-κB activation:: A new class of myeloprotective agents [J].
Bar-Yehuda, S ;
Madi, L ;
Barak, D ;
Mittelman, M ;
Ardon, E ;
Ochaion, A ;
Cohn, S ;
Fishman, P .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (12) :1390-1398
[5]   HUMAN PROTOONCOGENE C-JUN ENCODES A DNA-BINDING PROTEIN WITH STRUCTURAL AND FUNCTIONAL-PROPERTIES OF TRANSCRIPTION FACTOR AP-1 [J].
BOHMANN, D ;
BOS, TJ ;
ADMON, A ;
NISHIMURA, T ;
VOGT, PK ;
TJIAN, R .
SCIENCE, 1987, 238 (4832) :1386-1392
[6]   REGULATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR EXPRESSION BY ONCOSTATIN-M [J].
BROWN, TJ ;
LIU, JW ;
BRASHEMSTEIN, C ;
SHOYAB, M .
BLOOD, 1993, 82 (01) :33-37
[7]  
DEMETRI GD, 1989, BLOOD, V74, P940
[8]  
FAHEY RJ, 1951, CANCER, V4, P930, DOI 10.1002/1097-0142(195109)4:5<930::AID-CNCR2820040506>3.0.CO
[9]  
2-H
[10]  
GABRILOVE JL, 1985, BLOOD, V66, P407